Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (2,963,072) $ (5,069,818)
Adjustments to reconcile net loss to net cash used in operating activities:    
Acquired in-process research and development 0 1,305,000
Amortization of right of use asset 0 27,043
Share-based expense 208,507 392,829
Changes in operating assets and liabilities:    
Prepaid expenses and other (924,468) 133,253
Other assets 362,500 (313,920)
Accounts payable, accrued expenses and other liabilities (4,659) (370,245)
Net cash used in operating activities (3,321,192) (3,895,858)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Net cash paid to acquire in-process research and development 0 (500,000)
Net cash used in investing activities 0 (500,000)
Net change in cash (3,321,192) (4,395,858)
Cash at beginning of period 13,097,265 18,244,030
Cash at end of period 9,776,073 13,848,172
SUPPLEMENTAL CASH FLOW INFORMATION:    
Cash paid for interest 0 0
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Issuance of common stock from cashless exercise of purchase warrants 2
Issuance of common stock to acquire in-process research and development $ 0 $ 805,000